NCT00393263View on ClinicalTrials.gov

Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Lichen Sclerosus

Interventions

DRUG

pimecrolimus and clobetasol

DRUG

clobetasol 0.05% cream

twice daily for three months

Trial Locations (1)

21012

Center for VulvoVaginal Disorders, Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Center for Vulvovaginal Disorders

OTHER